Clinical diagnosis of malignant pleural mesothelioma.

@article{Bianco2018ClinicalDO,
  title={Clinical diagnosis of malignant pleural mesothelioma.},
  author={A. Bianco and T. Valente and M. L. De Rimini and G. Sica and A. Fiorelli},
  journal={Journal of thoracic disease},
  year={2018},
  volume={10 Suppl 2},
  pages={
          S253-S261
        }
}
  • A. Bianco, T. Valente, +2 authors A. Fiorelli
  • Published 2018
  • Medicine
  • Journal of thoracic disease
  • Malignant pleural mesothelioma (MPM) is a tumour which, despite progress in diagnostic procedures and biomolecular research, has poor prognosis. Symptoms reflect extension of disease and include shortness of breath and chest pain. Unexplained pleural effusion and pleural pain in patients exposed to asbestos should raise the suspicion of MPM. MPM diagnosis requires imaging procedures X-ray and computed tomography (CT) scans; magnetic resonance imaging (MRI) better defines the extension of the… CONTINUE READING
    11 Citations
    Malignant Pleural Mesothelioma: an Update for Pulmonologists
    • 2
    Diagnostic yield of rapid on-site evaluation transbronchial needle aspiration versus conventional transbronchial needle aspiration: a single center experience.
    • PDF

    References

    SHOWING 1-10 OF 46 REFERENCES
    Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma.
    • 57
    Management of malignant pleural mesothelioma – part 1: epidemiology, diagnosis, and staging
    • 17
    • Highly Influential
    • PDF
    Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
    • 87
    • Highly Influential
    • PDF
    Morphologic and functional imaging of malignant pleural mesothelioma.
    • 69
    • PDF
    [Clinical diagnosis of malignant pleural mesothelioma].
    • 1
    Response evaluation in mesothelioma: Beyond RECIST.
    • 17
    Malignant pleural mesothelioma: key determinants in tailoring the right treatment for the right patient.
    • 5
    Localized malignant pleural sarcomatoid mesothelioma misdiagnosed as benign localized fibrous tumor.
    • 11
    Serum Mesothelin, Osteopontin and Vimentin: Useful Markers for Clinical Monitoring of Malignant Pleural Mesothelioma
    • 19
    Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis
    • 17
    • PDF